K36 Therapeutics Announces $70 Million Series B Financing to Fund Clinical Proof of Concept of KTX-1001, First-in-class Inhibitor of MMSET for Treatment of Multiple Myeloma Patients with Genetic Translocation (4;14) June 28, 2023
Menopause care is still a largely untapped market. Here’s why investors and startups should dive in June 28, 2023
First AI-generated drug enters human clinical trials, targeting chronic lung disease patients June 28, 2023
First Drug Discovered and Designed with Generative AI Enters Phase II Trials, with First Patients Dosed June 27, 2023
Invetx Appoints Dr. Marcus Remmers, Novo Holdings Partner and Animal Health Industry Leader, to Board of Directors June 26, 2023